Abbott Molecular is committed to exploring new clinical frontiers through the development and delivery of innovative systems and assay solutions that will aid in the diagnosis of diseases, selection of appropriate therapies and monitoring of disease recurrence at the molecular level. We are investing in the development of new biomarkers to expand our existing oncology portfolio.